The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 26, 2025 for Aayush Agrawal, ....
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aayush Agrawal, promoter and trustee of the Aayush Agrawal Trust, has created a pledge on 1,70,000 shares (0.14% of total share capital) of Ajanta Pharma Ltd on November 19, 2025. The reason stated is to raise a new loan, with Bajaj Finance Ltd as the lender. After this pledge, the total encumbered shares held by the Aayush Agrawal Trust stand at 67,50,002 shares, or 5.40% of the company's share capital. The trust's overall promoter holding remains at 1,41,12,924 shares (11.30%). Other promoter-group entities such as the Ravi P Agrawal Trust (4.85% encumbered) also have existing pledged shares. This is a routine encumbrance disclosure filed under SEBI SAST Regulations.
This is a small pledge creation by a single promoter entity and is unlikely to materially impact the stock price. It signals the promoter is using a small portion of their holdings as collateral for personal borrowing, which is common but worth tracking if additional pledges are created in the future.